Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FENNEC PHARMACEUTICALS INC.

(FENC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Fennec Announces Results of Annual Meeting

06/29/2021 | 05:30pm EDT

RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021.

Detailed results of the vote for the election of directors are set out below:

Name of NomineeVotes For% Votes ForVotes Withheld% Votes Withheld
Dr. Khalid Islam13,646,93499.05%130,5900.95%
Mr. Adrian Haigh13,419,74997.40%357,7752.60%
Mr. Chris A. Rallis13,611,81898.80%165,7061.20%
Dr. Marco Brughera13,517,83998.12%259,6851.88%
Dr. Jodi Cook13,519,40098.13%258,1241.87%
Mr. Rostislav Raykov13,656,95799.12%120,5670.88%

Shareholders also voted 99.88% in favour of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, and voted 97.48% in favour of the compensation paid to the Company’s named executive officers.

For further information, please contact:

Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144


Primary Logo


© GlobeNewswire 2021
All news about FENNEC PHARMACEUTICALS INC.
09/09FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
AQ
08/10FENNEC PHARMACEUTICALS : Wedbush Lifts Price Target for Fennec Pharmaceuticals t..
MT
08/10FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
AQ
08/10FENNEC PHARMACEUTICALS : Reports Q2 Net loss of US$0.15 Per Share; Provides Busi..
MT
08/10FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Ne..
MT
08/10FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Ne..
MT
08/10Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Pr..
GL
08/06NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
06/30FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holder..
AQ
06/29Fennec Announces Results of Annual Meeting
GL
More news
Analyst Recommendations on FENNEC PHARMACEUTICALS INC.
More recommendations
Financials (USD)
Sales 2021 21,0 M - -
Net income 2021 -17,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -12,8x
Yield 2021 -
Capitalization 220 M 220 M -
Capi. / Sales 2021 10,5x
Capi. / Sales 2022 10,9x
Nbr of Employees 9
Free-Float 83,1%
Chart FENNEC PHARMACEUTICALS INC.
Duration : Period :
Fennec Pharmaceuticals Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FENNEC PHARMACEUTICALS INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 8,46 $
Average target price 13,60 $
Spread / Average Target 60,8%
EPS Revisions
Managers and Directors
Rostislav C. Raykov Chief Executive Officer & Director
Robert C. Andrade Chief Financial Officer
Khalid Islam Chairman
Chris A. Rallis Independent Director
Adrian James Haigh Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FENNEC PHARMACEUTICALS INC.13.56%220
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850